Loading…
SEC Form 144 at Ocular Therapeutix
Ocular Therapeutix · OCUL · Reported Oct 2, 2026
SEC Form 144 for Ocular Therapeutix (OCUL), reported Oct 2, 2026, explained in plain words, with every field of the record side by side with the official document.
Amount
Filed
Compared with the past
Related filings
The filing, in plain words
DetailContextCompared withValueSource
OQRO
One filing, read in full
Every field of the record next to the official document, with how it compares with the past.
Unlock OQRO Pro
Already a member? Sign in
What this page holds
- The filing in plain words
- Context: how it compares with the past
- Related filings at the same company
- A link to the official record
What OQRO is
OQRO reads the public record for US-listed companies — insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings, and federal contract awards — and puts each one in plain words next to the filing it came from. It describes what was disclosed. It does not give investment advice or tell you what to buy.
Want to see real filings before you pay? The home page shows live ones, free, with the link to each source document.